CRIS Current Research Information System

BOVE, MARILISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.250
AS - Asia 1.849
EU - Europa 1.481
SA - Sud America 132
AF - Africa 109
OC - Oceania 2
Totale 5.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.230
SG - Singapore 581
CN - Cina 579
GB - Regno Unito 396
VN - Vietnam 264
IT - Italia 232
DE - Germania 228
SE - Svezia 166
HK - Hong Kong 165
IN - India 110
BR - Brasile 86
UA - Ucraina 81
RU - Federazione Russa 70
FR - Francia 69
IE - Irlanda 66
KR - Corea 60
CI - Costa d'Avorio 48
NL - Olanda 39
EE - Estonia 30
ZA - Sudafrica 29
JO - Giordania 28
BG - Bulgaria 22
TG - Togo 22
AR - Argentina 21
CH - Svizzera 18
JP - Giappone 14
CL - Cile 12
MX - Messico 12
GR - Grecia 11
ID - Indonesia 11
FI - Finlandia 10
ES - Italia 8
AT - Austria 7
RO - Romania 7
SC - Seychelles 7
TR - Turchia 7
BD - Bangladesh 6
BE - Belgio 6
CA - Canada 5
EC - Ecuador 5
IQ - Iraq 5
PL - Polonia 5
CO - Colombia 3
IR - Iran 3
LT - Lituania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
KZ - Kazakistan 2
MY - Malesia 2
PK - Pakistan 2
UZ - Uzbekistan 2
AD - Andorra 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
CR - Costa Rica 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MK - Macedonia 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.823
Salva come PNG Salva come JPEG
Città #
Singapore 362
Southend 352
Fairfield 246
Ashburn 221
Santa Clara 179
Hong Kong 163
Hefei 148
Chandler 137
Woodbridge 128
Seattle 106
Houston 99
Wilmington 95
Princeton 92
Cambridge 91
Beijing 68
Ann Arbor 67
Dublin 65
Ho Chi Minh City 64
Dong Ket 60
Boardman 59
Seoul 59
Abidjan 48
Hanoi 48
Turin 47
Jacksonville 45
Westminster 39
Nanjing 36
Berlin 34
Buffalo 34
Los Angeles 30
Padova 30
Amman 28
Bremen 28
Milan 24
Lomé 22
Sofia 22
Bologna 19
Hebei 18
Jinan 18
The Dalles 18
Dearborn 17
Saint Petersburg 17
Bengaluru 16
Bern 16
San Diego 14
Tokyo 14
Da Nang 13
Nanchang 13
Des Moines 11
Shenyang 11
São Paulo 11
Changsha 10
Dallas 10
Guangzhou 10
Shanghai 10
Redondo Beach 9
Rome 9
Taizhou 9
Hải Dương 8
Medford 8
New York 8
Chicago 7
London 7
Olalla 7
Zhengzhou 7
Helsinki 6
Mexico City 6
Paris 6
Redwood City 6
Brescia 5
Brussels 5
Bühl 5
Düsseldorf 5
Falkenstein 5
Falls Church 5
Groningen 5
Ha Long 5
Jakarta 5
Jiaxing 5
Mahé 5
Moscow 5
Mountain View 5
Ningbo 5
Nuremberg 5
Rio de Janeiro 5
Tongling 5
Verona 5
Xi'an 5
Yubileyny 5
Zanica 5
Barcelona 4
Manchester 4
Porto Alegre 4
San Venanzo 4
Santiago 4
Tianjin 4
Vũng Tàu 4
Amsterdam 3
Baoding 3
Biên Hòa 3
Totale 3.887
Salva come PNG Salva come JPEG
Nome #
Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial 195
Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209 176
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 163
Sources of variabilità of plasma HDL-cholesterol levels. 159
An evidence-based review on urate-lowering treatments: Implications for optimal treatment of chronic hyperuricemia 152
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study 141
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. 134
null 131
Novel mutation in the ApoB Gene (Apo B-15.56): A Case Report. 130
Optimizing Lipid Pattern by Adding a Combined Nutraceutical or Pravastatin to Fenofibrate Treatment in Hypertriglyceridemic Subjects: Single Site, Randomized, Open-Label, Post-Market Clinical Investigation 124
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 122
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study. 121
Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project 120
Effetto di un nutraceutico combinato su sintomi menopausali e fattori di rischio cardiometabolici in donne dislipidemiche affette da sindrome perimenopausale 116
Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial 111
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial 109
Long-term effectiveness and safety of a nutraceutical based approach to reduce cholesterolemia in statin intolerant subjects with and without metabolic syndrome. 105
MMP-2, MMP-9 and their inhibitors in FCH, MS, FCH+MS and control subjects: a comparison study. 102
LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort 100
Efficacy and safety of Armolipid Plus®: an updated PRISMA compliant systematic review and meta-analysis of randomized controlled clinical trials. 100
LDL-oxidation, serum uric acid and pulse-wave velocity relationship in chronic kidney disease: Data from the Brisighella heart study cohort 99
Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects. 99
null 98
Role of olive oil in the health: results form the Eurolive Study. 98
Regression of atherosclerosis after one year of treatment with low dosed rosuvastatin: the role of patient selection. 98
Estimating the burden of hyperlipidemia in a hypertensive ambulatory population 96
Emerging drugs for the treatment of hypercholesterolemia 96
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. 94
null 93
Non conventional cardiovascular risk factors distribution in FCH, MS, FCH+MS and control subjects: towards a full disease characterization. 93
Effect of quantitative and qualitative diet prescription on children behavior after diagnosis of heterozygous familial hypercholesterolemia. 93
Prevalent seasoning and cooking fats, arterial stiffness and lipid pattern in a rural population sample: data from the Brisighella Heart Study 93
Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial 92
Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection 87
Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. 86
CARDIOVASCULAR DISEASE RISK PERCEPTION IN PATIENTS AFFECTED BY FAMILIAL HYPERLIPIDAEMIAS IN SPECIALIST SETTING 84
Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic 83
Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate 82
null 82
Effect of a sequential training program on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome 82
Prevalence of Hypo- and Hyperalphalipoproteinemia according to different diagnostic criteria in the massa lombarda project cohort 78
EFFECT OF QUANTITATIVE AND QUALITATIVE DIET PRESCRIPTION ON CHILDREN BEHAVIOUR AFTER A DIAGNOSIS OF FAMILIAL DYSLIPIDEMIA 76
Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia. 75
null 75
null 73
Short-Term Effects of Dry Extracts of Artichokeand Berberis in Hypercholesterolemic Patients Without Cardiovascular Disease 73
Successful treatment of a patient with mitochondrial myopathy with alirocumab 73
null 71
Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. 71
NUTRACEUTICAL EFFECTS ON GLUCOSE AND LIPID METABOLISM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE: A PILOT, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL 68
null 68
Efficacy of soluble fiber supplementation in CVD risk management of patients affected by metabolic syndrome: A 6-months, open-label, RCT 67
Evaluation of the short term efficacy and tolerability of a combined nutraceutical with lipid lowering properties: a randomized clinical trial. 66
null 64
null 62
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. 59
null 51
MMP-2, MMP-9 and their inhibitors and other prothrombotic risk factors plasma level in FCH, MS, FCH plus MS and control subjects 50
Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia 50
Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product 43
Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: An epidemiological approach 41
Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial 40
The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function 39
Effect of a combined mulberry-sage dietary supplement on food craving and body weight: a pilot clinical trial 37
Sources of variability of plasma HDL-cholesterol levels. 29
Totale 5.938
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 27 13 27 52 37 24 95
2021/2022737 73 17 40 26 83 50 9 37 38 24 214 126
2022/2023856 65 94 25 139 57 53 33 43 190 37 83 37
2023/2024196 4 45 17 26 15 34 12 20 2 15 3 3
2024/20251.087 24 134 88 56 257 68 91 24 5 53 40 247
2025/20261.316 205 311 249 172 285 94 0 0 0 0 0 0
Totale 5.938